Gene: BCL6B
Official Full Name: BCL6B transcription repressorprovided by HGNC
Gene Summary: Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in several processes, including regulation of gene expression; regulation of inflammatory response; and type 2 immune response. Predicted to be located in nucleus. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA03591 | BCL6B Knockout cell line (AC16) | Human | BCL6B | 1:3-1:4 | negative | Online Inquiry |
| KOA19038 | BCL6B Knockout cell line (BEAS-2B) | Human | BCL6B | 1:3~1:4 | negative | Online Inquiry |
| KOA34488 | BCL6B Knockout cell line (U-2932) | Human | BCL6B | 1:2-1:4 | negative | Online Inquiry |
| KOA49891 | BCL6B Knockout cell line (TPC-1) | Human | BCL6B | 1:5-1:8 | negative | Online Inquiry |
| KOA65297 | BCL6B Knockout cell line (NCM460) | Human | BCL6B | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.